<DOC>
	<DOC>NCT00541450</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of sitagliptin and MK0431A in comparison to a commonly used medication in patients with type 2 diabetes.</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients between the ages of 18 and 78 with type 2 diabetes mellitus Patient has not been on any antihyperglycemic agent (Insulin or oral) in the last 3 months Patient has a history of type 1 diabetes mellitus or a history of ketoacidosis Patient has previously been treated with sitagliptin or has previously been in a study using a DPP4 inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>